Stock DNA
Hospital/Nursing Management
SEK 27 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.07
-119.39%
5.12
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Sep 2024)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
80.28%
0%
80.28%
6 Months
82.86%
0%
82.86%
1 Year
23.08%
0%
23.08%
2 Years
-34.36%
0%
-34.36%
3 Years
-69.3%
0%
-69.3%
4 Years
-72.32%
0%
-72.32%
5 Years
-74.19%
0%
-74.19%
Alteco Medical AB for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-13.38%
EBIT Growth (5y)
4.59%
EBIT to Interest (avg)
-5.94
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.92
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.12
EV to EBIT
-3.99
EV to EBITDA
-3.99
EV to Capital Employed
5.44
EV to Sales
9.20
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-136.29%
ROE (Latest)
-119.39%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Jun 2023
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (8.94%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ
Sep'24
Jun'24
Change(%)
Net Sales
0.70
0.50
40.00%
Operating Profit (PBDIT) excl Other Income
-1.00
-1.20
16.67%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.00
-1.30
23.08%
Operating Profit Margin (Excl OI)
-1,497.40%
-2,386.20%
88.88%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2024 is 40.00% vs -37.50% in Jun 2024
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2024 is 23.08% vs 18.75% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
6.10
8.20
-25.61%
Operating Profit (PBDIT) excl Other Income
-6.10
-5.80
-5.17%
Interest
0.20
0.10
100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-6.20
-5.80
-6.90%
Operating Profit Margin (Excl OI)
-1,059.50%
-761.60%
-29.79%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -25.61% vs -1.20% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -6.90% vs -48.72% in Dec 2022
About Alteco Medical AB 
Alteco Medical AB
Hospital/Nursing Management
Alteco Medical AB is a Sweden-based company engaged in the healthcare and biotechnology business sector. The Company develops medical devices focusing on intensive care. The Company’s product named Alteco LPS Adsorber is used within the sepsis area and reduces endotoxin (LPS) levels in blood and positive indications on sepsis markers. The product is used for patients with verified gram-negative sepsis caused by gastro-intestinal perforation, complications after abdominal surgery and uro-genital sepsis but patients with other sources of sepsis such as burns and complications after organ transplant could also respond to treatment. In addition, the Company provides various applications, including gram negative infection, abdominal sepsis, sepsis postoperatively or post trauma and lung originated sepsis, among others.
Company Coordinates 
Company Details
Hostbruksvagen 8 , LUND None : 226 60
Registrar Details






